A detailed history of Bank Of Montreal transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 185,291 shares of REGN stock, worth $153 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
185,291
Previous 229,053 19.11%
Holding current value
$153 Million
Previous $220 Million 11.66%
% of portfolio
0.1%
Previous 0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$883.2 - $1071.19 $38.7 Million - $46.9 Million
-43,762 Reduced 19.11%
185,291 $195 Million
Q1 2024

May 13, 2024

SELL
$902.69 - $993.35 $50.7 Million - $55.7 Million
-56,112 Reduced 19.68%
229,053 $220 Million
Q4 2023

Feb 08, 2024

BUY
$775.18 - $881.7 $80.7 Million - $91.7 Million
104,050 Added 57.45%
285,165 $250 Million
Q3 2023

Nov 01, 2023

BUY
$692.45 - $844.37 $23.1 Million - $28.1 Million
33,317 Added 22.54%
181,115 $149 Million
Q2 2023

Aug 02, 2023

BUY
$700.03 - $830.35 $26.4 Million - $31.3 Million
37,695 Added 34.24%
147,798 $106 Million
Q1 2023

Jun 13, 2024

SELL
$680.49 - $826.97 $97.1 Million - $118 Million
-142,764 Reduced 62.33%
86,289 $70.9 Million
Q4 2022

Feb 01, 2023

BUY
$705.89 - $766.39 $27.5 Million - $29.8 Million
38,901 Added 54.63%
110,103 $79.4 Million
Q3 2022

Nov 10, 2022

SELL
$573.97 - $724.32 $31.9 Million - $40.2 Million
-55,551 Reduced 43.83%
71,202 $49.8 Million
Q2 2022

Aug 11, 2022

BUY
$548.35 - $738.84 $21.2 Million - $28.6 Million
38,662 Added 43.89%
126,753 $76.4 Million
Q1 2022

May 12, 2022

SELL
$595.12 - $698.43 $21.1 Million - $24.7 Million
-35,419 Reduced 28.68%
88,091 $61.3 Million
Q4 2021

Feb 11, 2022

SELL
$543.48 - $670.97 $19.4 Million - $24 Million
-35,725 Reduced 22.44%
123,510 $80.3 Million
Q3 2021

Nov 12, 2021

BUY
$574.03 - $680.96 $17.9 Million - $21.3 Million
31,248 Added 24.41%
159,235 $97.2 Million
Q2 2021

Aug 12, 2021

BUY
$472.8 - $558.54 $60.5 Million - $71.5 Million
127,987 New
127,987 $70 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $88.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.